Condition: Pediatric Obstructive Sleep Apnea · Down Syndrome (DS) · Sponsor: Inspire Medical Systems, Inc.
The purpose of this Post Approval research study is to assess ongoing safety and effectiveness of the Inspire therapy in adolescents and young adults (age 13-18) with Down syndrome and severe sleep apnea. The objective of the study is to provide an ongoing safety and effectiveness assessment of the Inspire UAS System in the Pediatric Down syndrome population.
This description comes directly from the study's public registry record.
Angela Chapin, Sr. Clinical Study Manager · 763.392.7222 · angelachapin@inspiresleep.com
Gwen Gimmestad, VP Clinical · 763.392.9966 · gwengimmestad@inspiresleep.com
Always discuss trial participation with your own doctor first.
| Phoenix Children's Hospital | Phoenix, Arizona, United States | Not Yet Recruiting |
| Children's Hospital Orange County | Orange, California, United States | Not Yet Recruiting |
| University of South Florida Morsani College of Medicine | Tampa, Florida, United States | Not Yet Recruiting |
| Northwell Cohen Children's Hospital | Queens, New York, United States | Not Yet Recruiting |
| Cleveland Clinic Foundation | Cleveland, Ohio, United States | Not Yet Recruiting |
| Baylor College of Medicine/ Texas Children's Hospital | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06851338